EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 12 (Décembre 2007) Med Sci (Paris), 23 12 (2007) 1133-1140 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 12, Décembre 2007
Page(s) 1133 - 1140
Section M/S revues
DOI https://doi.org/10.1051/medsci/200723121133
Published online 15 December 2007
  1. Birnbaum D, Bertucci F, Ginestier C, et al. Basal and luminal breast cancers: basic or luminous ? Int J Oncol 2004; 25 : 249–58. [Google Scholar]
  2. Smith GH. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005; 132 : 681–7. [Google Scholar]
  3. Deugnier MA, Petit V, Taddei de la Housseraye I, et al. Vers la caractérisation des cellules souches de la glande mammaire adulte. Med Sci (Paris) 2007; 23 : 1125–32. [Google Scholar]
  4. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439 : 84–8. [Google Scholar]
  5. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17 : 1253–70. [Google Scholar]
  6. Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004; 101 : 4966–71. [Google Scholar]
  7. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414 : 105–11. [Google Scholar]
  8. Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006; 442 : 818–822. [Google Scholar]
  9. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea: a paradigm shift. Cancer Res 2006; 66 : 1883–90. [Google Scholar]
  10. Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006; 12 : 5615–21. [Google Scholar]
  11. Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/. Breast Cancer Res 2006; 8 : R59. [Google Scholar]
  12. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3 : 730–7. [Google Scholar]
  13. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67 : 1030–7. [Google Scholar]
  14. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104 : 973–8. [Google Scholar]
  15. Al-Hajj M, Wicha MS, ito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100 : 3983–3988. [Google Scholar]
  16. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65 : 10946–51. [Google Scholar]
  17. Fang D, Nguyen TK, Leishear K, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65 : 9328–37. [Google Scholar]
  18. Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004; 103 : 2332–6. [Google Scholar]
  19. O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445 : 106–10. [Google Scholar]
  20. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445 : 111–5. [Google Scholar]
  21. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63 : 5821–8. [Google Scholar]
  22. Lou H, Dean M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene 2007; 26 : 1357–60. [Google Scholar]
  23. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004; 101 : 781–6. [Google Scholar]
  24. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 2005; 65 : 6207–19. [Google Scholar]
  25. Ginestier C, Hur MH, Charaffe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1 : 555–67. [Google Scholar]
  26. Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006; 24 : 975–85. [Google Scholar]
  27. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65 : 5506–11. [Google Scholar]
  28. Robey RW, Polgar O, Deeken J, et al. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 2007; 26 : 39–57. [Google Scholar]
  29. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444 : 756–60. [Google Scholar]
  30. Hambardzumyan D, Squatrito M, Holland EC. Radiation resistance and stem-like cells in brain tumors. Cancer Cell 2006; 10 : 454–6. [Google Scholar]
  31. Phillips TM, McBride WH, Pajonk F. The response of CD24 (-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98 : 1777–85. [Google Scholar]
  32. Clement V, Sanchez P, de TN, et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17 : 165–72. [Google Scholar]
  33. Vujovic S, Henderson SR, Flanagan AM, Clements MO. Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cells. Cell Prolif 2007; 40 : 185–95. [Google Scholar]
  34. Farnie G, Clarke RB, Spence K, et al. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 2007; 99 : 616–27. [Google Scholar]
  35. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 2002; 99 : 759–67. [Google Scholar]
  36. Van HJ, Van GR, Bruwiere H, et al. Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. Br J Cancer 2002; 86 : 605–11. [Google Scholar]
  37. Wouters W, van DJ, Dillen A, et al. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res 1992; 52 : 2841–6. [Google Scholar]
  38. Patel JB, Mehta J, Belosay A, et al. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer 2007; 96 : 1204–15. [Google Scholar]
  39. Parisotto M, Brodeur H, Bhat PV, Mader S. Retinoid metabolism and cancer. Med Sci (Paris) 2006; 22 : 1101–6. [Google Scholar]
  40. Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12 : 1167–74. [Google Scholar]
  41. Cheung AM, Mak TW. PTEN in the haematopoietic system and its therapeutic indications. Trends Mol Med 2006; 12 : 503–5. [Google Scholar]
  42. He XC, Yin T, Grindley JC, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 2007; 39 : 189–98. [Google Scholar]
  43. Nagata Y, Lan KH, Zhou X, et al. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell 2004; 6 : 117–27. [Google Scholar]
  44. Durante F. Nesso fisio-pathologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni. Arch Memor Observ Chir Pract 1874; 11 : 217–26. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.